Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms’ tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine

Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms’ tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine

Background A chemoimmunotherapy regimen consisting of a novel Wilms’ tumor 1 (WT1) peptide-pulsed dendritic cell (WT1-DC) vaccine and multiagent chemotherapy was observed to modulate the tumor microenvironment (TME) to an immunostimulatory state, resulting in conversion surgery in seven out of nine...

Full description

Saved in:
Bibliographic Details
Main Authors: Nobuhiro Sato, Shigetaka Shimodaira, Masayuki Saruta, Yoko Shimizu, Shigeo Koido, Junichi Taguchi, Masamori Shimabuku, Tuuse Bito, Zensho Ito, Kan Uchiyama, Toshifumi Ohkusa, Haruo Sugiyama, Soyoko Morimoto, Yusuke Oji, Yoshihiro Oka, Masaki Ito
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/7/e011426.full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://jitc.bmj.com/content/13/7/e011426.full

Similar Items